Sung-Sun Cho
Directeur Général chez YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.
Postes actifs de Sung-Sun Cho
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - |
Historique de carrière de Sung-Sun Cho
Anciens postes connus de Sung-Sun Cho
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Directeur Général | - | - |
Statistiques
Internationale
| Corée du Sud | 3 |
Opérationnelle
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
| Entreprise privées | 1 |
|---|---|
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Bourse
- Insiders
- Sung-Sun Cho
- Expérience
